Improved seizure control in patients with recurrent glioblastoma treated with bevacizumab

被引：4
|
作者：
Hertler, Caroline [1 ,2 ,3 ]
Seystahl, Katharina [1 ,2 ]
Le Rhun, Emilie [1 ,2 ,4 ]
Wirsching, Hans-Georg [1 ,2 ]
Roth, Patrick [1 ,2 ]
Weller, Michael [1 ,2 ]
Gramatzki, Dorothee [1 ,2 ]
机构：
[1] Univ Hosp, Clin Neurosci Ctr, Dept Neurol, Frauenklin str 26, CH-8091 Zurich, Switzerland
[2] Univ Zurich, Frauenklin str 26, CH-8091 Zurich, Switzerland
[3] Univ Hosp Zurich, Competence Ctr Palliat Care, Zurich, Switzerland
[4] Univ Hosp, Clin Neurosci Ctr, Dept Neurosurg, Zurich, Switzerland
来源：
NEURO-ONCOLOGY | 2022年 / 24卷 / 11期
关键词：
D O I：
10.1093/neuonc/noac172
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：2001 / 2004
页数：4
相关论文
共 50 条
  • [1] SEIZURE CONTROL BY BEVACIZUMAB IN GLIOBLASTOMA PATIENTS
    Hertler, Caroline
    Seystahl, Katharina
    Le Rhun, Emilie
    Wirsching, Georg
    Roth, Patrick
    Weller, Michael
    Gramatzki, Dorothee
    [J]. NEURO-ONCOLOGY, 2022, 24 : 111 - 111
  • [2] Bevacizumab-Induced Hypertension Is a Predictive Marker for Improved Outcomes in Patients With Recurrent Glioblastoma Treated With Bevacizumab
    Zhong, Jim
    Ali, Arif N.
    Voloschin, Alfredo D.
    Liu, Yuan
    Curran, Walter J., Jr.
    Crocker, Ian R.
    Shu, Hui-Kuo G.
    [J]. CANCER, 2015, 121 (09) : 1456 - 1462
  • [3] Patterns of progression in patients with recurrent glioblastoma treated with bevacizumab
    Pope, W. B.
    Xia, Q.
    Paton, V. E.
    Das, A.
    Hambleton, J.
    Kim, H. J.
    Huo, J.
    Brown, M. S.
    Goldin, J.
    Cloughesy, T.
    [J]. NEUROLOGY, 2011, 76 (05) : 432 - 437
  • [4] Neurocognitive function in patients with recurrent glioblastoma treated with bevacizumab
    Wefel, Jeffrey S.
    Cloughesy, Timothy
    Zazzali, James L.
    Zheng, Maoxia
    Prados, Michael
    Wen, Patrick Y.
    Mikkelsen, Tom
    Schiff, David
    Abrey, Lauren E.
    Yung, W. K. Alfred
    Paleologos, Nina
    Nicholas, Martin K.
    Jensen, Randy
    Vredenburgh, James
    Das, Asha
    Friedman, Henry S.
    [J]. NEURO-ONCOLOGY, 2011, 13 (06) : 660 - 668
  • [5] Prognostic factors in recurrent glioblastoma patients treated with bevacizumab
    Schaub, Christina
    Tichy, Julia
    Schaefer, Niklas
    Franz, Kea
    Mack, Frederic
    Mittelbronn, Michel
    Kebir, Sied
    Thiepold, Anna-Luisa
    Waha, Andreas
    Filmann, Natalie
    Banat, Mohammed
    Fimmers, Rolf
    Steinbach, Joachim P.
    Herrlinger, Ulrich
    Rieger, Johannes
    Glas, Martin
    Baehr, Oliver
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2016, 129 (01) : 93 - 100
  • [6] Prognostic factors in recurrent glioblastoma patients treated with bevacizumab
    Christina Schaub
    Julia Tichy
    Niklas Schäfer
    Kea Franz
    Frederic Mack
    Michel Mittelbronn
    Sied Kebir
    Anna-Luisa Thiepold
    Andreas Waha
    Natalie Filmann
    Mohammed Banat
    Rolf Fimmers
    Joachim P. Steinbach
    Ulrich Herrlinger
    Johannes Rieger
    Martin Glas
    Oliver Bähr
    [J]. Journal of Neuro-Oncology, 2016, 129 : 93 - 100
  • [7] Response as a predictor of survival in patients with recurrent glioblastoma treated with bevacizumab
    Prados, Michael
    Cloughesy, Timothy
    Samant, Meghna
    Fang, Liang
    Wen, Patrick Y.
    Mikkelsen, Tom
    Schiff, David
    Abrey, Lauren E.
    Yung, W. K. Alfred
    Paleologos, Nina
    Nicholas, Martin K.
    Jensen, Randy
    Vredenburgh, James
    Das, Asha
    Friedman, Henry S.
    [J]. NEURO-ONCOLOGY, 2011, 13 (01) : 143 - 151
  • [8] Molecular analysis of a recurrent glioblastoma treated with bevacizumab
    Takuya Furuta
    Mitsutoshi Nakada
    Kouichi Misaki
    Yasunori Sato
    Yutaka Hayashi
    Yasuni Nakanuma
    Jun-ichiro Hamada
    [J]. Brain Tumor Pathology, 2014, 31 : 32 - 39
  • [9] Molecular analysis of a recurrent glioblastoma treated with bevacizumab
    Furuta, Takuya
    Nakada, Mitsutoshi
    Misaki, Kouichi
    Sato, Yasunori
    Hayashi, Yutaka
    Nakanuma, Yasuni
    Hamada, Jun-ichiro
    [J]. BRAIN TUMOR PATHOLOGY, 2014, 31 (01) : 32 - 39
  • [10] OUTCOMES OF RECURRENT GLIOBLASTOMA PATIENTS TREATED WITH BEVACIZUMAB AT A TERTIARY CARE CENTER
    Stevens, G. H. J.
    Sakruti, S.
    Griffin, S.
    Peereboom, D.
    Ahluwalia, M. S.
    [J]. NEURO-ONCOLOGY, 2014, 16
12345